TGFB1 and Ureteral obstruction: [38] demonstrated that the YAP inhibitor verteporfin significantly lowered CTGF and TGF-β levels in the renal tubulointerstitial and alleviated renal fibrosis due to unilateral ureteral obstruction (UUO).